AAPL340.97+4.33 (+1.29%) ▲|ABBV281.12+4.65 (+1.68%) ▲|ABT101.82+2.22 (+2.23%) ▲|ACN214.87+5.81 (+2.78%) ▲|ADBE238.14-4.13 (-1.70%) ▼|AMAT497.53-9.50 (-1.87%) ▼|AMD594.24-13.86 (-2.28%) ▼|AMGN417.57+2.70 (+0.65%) ▲|AMT182.56+0.32 (+0.18%) ▲|AMZN259.53-2.90 (-1.11%) ▼|AVGO354.73-6.81 (-1.88%) ▼|AXP311.53+3.36 (+1.09%) ▲|BA189.50-0.87 (-0.46%) ▼|BAC54.58+0.26 (+0.48%) ▲|BKNG158.43-1.91 (-1.19%) ▼|BLK1,083.92+1.53 (+0.14%) ▲|BMY57.58-1.54 (-2.60%) ▼|BNY142.85+0.14 (+0.10%) ▲|BRK-B517.60+1.98 (+0.38%) ▲|C131.92+2.28 (+1.76%) ▲|CAT799.37-1.10 (-0.14%) ▼|CL89.98+1.71 (+1.94%) ▲|CMCSA20.68+0.02 (+0.10%) ▲|COF201.14+1.88 (+0.94%) ▲|COP137.56+3.46 (+2.58%) ▲|COST959.44+12.52 (+1.32%) ▲|CRM233.92+4.79 (+2.09%) ▲|CSCO115.34-3.05 (-2.58%) ▼|CVS87.74+1.58 (+1.83%) ▲|CVX215.00+3.02 (+1.42%) ▲|DE632.61+11.68 (+1.88%) ▲|DHR221.20+1.39 (+0.63%) ▲|DIS108.49+0.44 (+0.41%) ▲|DUK117.69+1.04 (+0.89%) ▲|EMR162.46+0.63 (+0.39%) ▲|FDX292.23+0.52 (+0.18%) ▲|GD335.46+4.19 (+1.26%) ▲|GE308.64+0.44 (+0.14%) ▲|GEV996.80-7.93 (-0.79%) ▼|GILD150.43-0.74 (-0.49%) ▼|GM82.37-0.36 (-0.44%) ▼|GOOG348.97+1.11 (+0.32%) ▲|GOOGL352.72+1.06 (+0.30%) ▲|GS893.95-1.37 (-0.15%) ▼|HD290.62-0.12 (-0.04%) ▼|HON209.64+1.91 (+0.92%) ▲|IBM227.02-0.11 (-0.05%) ▼|INTC101.35-3.35 (-3.20%) ▼|INTU305.99+3.24 (+1.07%) ▲|ISRG427.64+3.68 (+0.87%) ▲|JNJ263.73+2.29 (+0.88%) ▲|JPM334.30+1.31 (+0.39%) ▲|KO89.79+1.74 (+1.98%) ▲|LIN487.35+3.62 (+0.75%) ▲|LLY1,182.62+3.35 (+0.28%) ▲|LMT511.88+2.29 (+0.45%) ▲|LOW185.57-0.43 (-0.23%) ▼|LRCX309.56-9.28 (-2.91%) ▼|MA595.09+5.95 (+1.01%) ▲|MCD235.65+0.42 (+0.18%) ▲|MDLZ61.79+1.38 (+2.28%) ▲|MDT91.93+3.45 (+3.90%) ▲|META742.96+24.29 (+3.38%) ▲|MMM160.89+0.93 (+0.58%) ▲|MO71.66-0.02 (-0.03%) ▼|MRK145.45-0.15 (-0.10%) ▼|MS190.02+0.00 (+0.00%) ▲|MSFT541.15+6.08 (+1.14%) ▲|MU989.04-39.96 (-3.88%) ▼|NEE78.51+1.13 (+1.46%) ▲|NFLX70.61+0.31 (+0.44%) ▲|NKE35.35+0.64 (+1.84%) ▲|NOW140.32-0.54 (-0.38%) ▼|NVDA226.32-2.96 (-1.29%) ▼|ORCL137.39-4.01 (-2.84%) ▼|PEP126.68+0.71 (+0.56%) ▲|PFE28.40+0.12 (+0.42%) ▲|PG153.20+1.97 (+1.30%) ▲|PLTR209.00-0.05 (-0.02%) ▼|PM202.00+0.81 (+0.40%) ▲|QCOM174.43-1.07 (-0.61%) ▼|RTX186.66+0.69 (+0.37%) ▲|SBUX92.29+1.54 (+1.69%) ▲|SCHW97.06+0.36 (+0.37%) ▲|SO87.04+0.87 (+1.01%) ▲|SPG201.41+1.99 (+1.00%) ▲|T22.49+0.31 (+1.40%) ▲|TMO662.24+4.22 (+0.64%) ▲|TMUS151.87+3.29 (+2.21%) ▲|TSLA378.03-4.67 (-1.22%) ▼|TXN281.74-2.00 (-0.70%) ▼|UBER71.50-0.01 (-0.01%) ▼|UNH378.52-0.78 (-0.21%) ▼|UNP281.57+3.23 (+1.16%) ▲|UPS95.34+0.77 (+0.81%) ▲|USB57.42+0.34 (+0.60%) ▲|V389.27+3.82 (+0.99%) ▲|VZ42.78+1.13 (+2.71%) ▲|WFC83.32-0.23 (-0.28%) ▼|WMT113.08+1.73 (+1.55%) ▲|XOM172.15+3.21 (+1.90%) ▲|AAPL340.97+4.33 (+1.29%) ▲|ABBV281.12+4.65 (+1.68%) ▲|ABT101.82+2.22 (+2.23%) ▲|ACN214.87+5.81 (+2.78%) ▲|ADBE238.14-4.13 (-1.70%) ▼|AMAT497.53-9.50 (-1.87%) ▼|AMD594.24-13.86 (-2.28%) ▼|AMGN417.57+2.70 (+0.65%) ▲|AMT182.56+0.32 (+0.18%) ▲|AMZN259.53-2.90 (-1.11%) ▼|AVGO354.73-6.81 (-1.88%) ▼|AXP311.53+3.36 (+1.09%) ▲|BA189.50-0.87 (-0.46%) ▼|BAC54.58+0.26 (+0.48%) ▲|BKNG158.43-1.91 (-1.19%) ▼|BLK1,083.92+1.53 (+0.14%) ▲|BMY57.58-1.54 (-2.60%) ▼|BNY142.85+0.14 (+0.10%) ▲|BRK-B517.60+1.98 (+0.38%) ▲|C131.92+2.28 (+1.76%) ▲|CAT799.37-1.10 (-0.14%) ▼|CL89.98+1.71 (+1.94%) ▲|CMCSA20.68+0.02 (+0.10%) ▲|COF201.14+1.88 (+0.94%) ▲|COP137.56+3.46 (+2.58%) ▲|COST959.44+12.52 (+1.32%) ▲|CRM233.92+4.79 (+2.09%) ▲|CSCO115.34-3.05 (-2.58%) ▼|CVS87.74+1.58 (+1.83%) ▲|CVX215.00+3.02 (+1.42%) ▲|DE632.61+11.68 (+1.88%) ▲|DHR221.20+1.39 (+0.63%) ▲|DIS108.49+0.44 (+0.41%) ▲|DUK117.69+1.04 (+0.89%) ▲|EMR162.46+0.63 (+0.39%) ▲|FDX292.23+0.52 (+0.18%) ▲|GD335.46+4.19 (+1.26%) ▲|GE308.64+0.44 (+0.14%) ▲|GEV996.80-7.93 (-0.79%) ▼|GILD150.43-0.74 (-0.49%) ▼|GM82.37-0.36 (-0.44%) ▼|GOOG348.97+1.11 (+0.32%) ▲|GOOGL352.72+1.06 (+0.30%) ▲|GS893.95-1.37 (-0.15%) ▼|HD290.62-0.12 (-0.04%) ▼|HON209.64+1.91 (+0.92%) ▲|IBM227.02-0.11 (-0.05%) ▼|INTC101.35-3.35 (-3.20%) ▼|INTU305.99+3.24 (+1.07%) ▲|ISRG427.64+3.68 (+0.87%) ▲|JNJ263.73+2.29 (+0.88%) ▲|JPM334.30+1.31 (+0.39%) ▲|KO89.79+1.74 (+1.98%) ▲|LIN487.35+3.62 (+0.75%) ▲|LLY1,182.62+3.35 (+0.28%) ▲|LMT511.88+2.29 (+0.45%) ▲|LOW185.57-0.43 (-0.23%) ▼|LRCX309.56-9.28 (-2.91%) ▼|MA595.09+5.95 (+1.01%) ▲|MCD235.65+0.42 (+0.18%) ▲|MDLZ61.79+1.38 (+2.28%) ▲|MDT91.93+3.45 (+3.90%) ▲|META742.96+24.29 (+3.38%) ▲|MMM160.89+0.93 (+0.58%) ▲|MO71.66-0.02 (-0.03%) ▼|MRK145.45-0.15 (-0.10%) ▼|MS190.02+0.00 (+0.00%) ▲|MSFT541.15+6.08 (+1.14%) ▲|MU989.04-39.96 (-3.88%) ▼|NEE78.51+1.13 (+1.46%) ▲|NFLX70.61+0.31 (+0.44%) ▲|NKE35.35+0.64 (+1.84%) ▲|NOW140.32-0.54 (-0.38%) ▼|NVDA226.32-2.96 (-1.29%) ▼|ORCL137.39-4.01 (-2.84%) ▼|PEP126.68+0.71 (+0.56%) ▲|PFE28.40+0.12 (+0.42%) ▲|PG153.20+1.97 (+1.30%) ▲|PLTR209.00-0.05 (-0.02%) ▼|PM202.00+0.81 (+0.40%) ▲|QCOM174.43-1.07 (-0.61%) ▼|RTX186.66+0.69 (+0.37%) ▲|SBUX92.29+1.54 (+1.69%) ▲|SCHW97.06+0.36 (+0.37%) ▲|SO87.04+0.87 (+1.01%) ▲|SPG201.41+1.99 (+1.00%) ▲|T22.49+0.31 (+1.40%) ▲|TMO662.24+4.22 (+0.64%) ▲|TMUS151.87+3.29 (+2.21%) ▲|TSLA378.03-4.67 (-1.22%) ▼|TXN281.74-2.00 (-0.70%) ▼|UBER71.50-0.01 (-0.01%) ▼|UNH378.52-0.78 (-0.21%) ▼|UNP281.57+3.23 (+1.16%) ▲|UPS95.34+0.77 (+0.81%) ▲|USB57.42+0.34 (+0.60%) ▲|V389.27+3.82 (+0.99%) ▲|VZ42.78+1.13 (+2.71%) ▲|WFC83.32-0.23 (-0.28%) ▼|WMT113.08+1.73 (+1.55%) ▲|XOM172.15+3.21 (+1.90%) ▲|
18.7 C
New York
Tuesday, October 13, 2026

Tag: company

newssourceFORcompanyinformationcontent1releasesmarket

The Institute for Coaching Innovation Announces Rebrand from Inc. 5000 CoachDiversity Institute

WASHINGTON, July 21, 2025 (GLOBE NEWSWIRE) -- The Institute for Coaching Innovation (ICI), a trailblazer in executive coaching and inclusive leadership development, announced that it will move forward from their former name, CoachDiversity Institute. The shift marks a significant evolution for the company, reflecting its commitment to future-focused leadership, global expansion, and scalable, tech-enabled learning.

Ampersand Capital Partners Invests in CurTec, a Global Leader in Pharma & Specialty Chemicals Bulk Packaging

Strategic partnership to accelerate U.S. growth, product innovation, and long-term value creation in life sciences supply chain. BOSTON and RIJEN, Netherlands, July 21, 2025 /PRNewswire/...

Vidsyn Discovery Proves Up Commercial Oil and Gas

Oslo, 21 July 2025 – DNO ASA, the Norwegian oil and gas operator, today confirmed a gas and condensate discovery on the Vidsyn prospect close to its producing Fenja oil and gas field, both within the Norwegian Sea license PL586. The Company has a 25 percent stake in the license, up from 7.5 percent prior to the recent acquisition of Sval Energi Group AS last month.

Stellantis Publishes Preliminary and Unaudited Key Figures for First Half 2025

Stellantis Publishes Preliminary and Unaudited Key Figures for First Half 2025

Appointment of Philippe de Rovira as Chief Executive Officer of Ayvens

The Board of Directors of Ayvens is pleased to announce the appointment of Philippe de Rovira as Chief Executive Officer (“Directeur Général”) following the recommendation of the Nomination Committee as part of its succession planning exercise. This appointment will become effective on 1st December 2025. Philippe de Rovira is due to be appointed by cooptation as member of the Board of Directors of Ayvens upon his taking responsibility as Chief Executive Officer of Ayvens.

Wolters Kluwer to divest its Finance, Risk and Regulatory Reporting unit

PRESS RELEASE

EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials

EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials 

Transaction in Own Shares

Transaction in own Shares

Change in Financial Calendar – 21 July 2025

Oslo, 21st of July - IDEX Biometrics ASA (OSE: IDEX) hereby announces a change to the company's financial calendar.

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary disease

Basel, 21 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today topline results from the pivotal phase IIb ALIENTO (n=1,301) and the phase III ARNASA (n=1,375) trials investigating astegolimab compared to placebo, on top of standard of care maintenance therapy in people with moderate to very severe chronic obstructive pulmonary disease (COPD). The studies included a broad population: both former and current smokers, regardless of blood eosinophil count, who have a history of frequent exacerbations.

S&P initiates coverage and assigns ‘A’ rating to Fidelidade

HONG KONG, July 21, 2025 /PRNewswire/ -- On 18 July 2025, – Standard & Poor's (S&P), one of the world's leading international credit rating...

KEENON Robotics Continues Global Lead in Commercial Service Robot Market, Securing Triple No.1 Rankings, IDC Reports

SHANGHAI, July 21, 2025 /PRNewswire/ -- KEENON Robotics continues to secure the #1 global position in the commercial service robot market, holding the No....

KEENON Robotics Continues Global Lead in Commercial Service Robot Market, Securing Triple No.1 Rankings, IDC Reports

SHANGHAI, July 21, 2025 /PRNewswire/ -- KEENON Robotics continues to secure the #1 global position in the commercial service robot market, holding the No....

The Wholesome Company Launches Rē•prev, a Calming Drink Mix for Anxiousness Support

Grapevine, TX, July 21, 2025 (GLOBE NEWSWIRE) -- The Wholesome Company, a wellness brand focused on holistic and evidence-aligned support for mental well-being, is pleased to announce the launch of Rē•prev, a breakthrough nutritional supplement formulated to help individuals reduce anxiousness, manage stress, and improve sleep quality. Designed for rapid absorption and daily use, Rē•prev combines naturally calming ingredients with a flexible, easy-to-use format aimed at supporting emotional resilience in today’s high-stress landscape.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers